Social networks
2,479Activities
Technologies
Entity types
Location
Ambachtenlaan 1, 3001 Leuven, Belgium
Leuven
Belgium
Employees
Scale: 2-10
Estimated: 34
Engaged corporates
0Added in Motherbase
1 year, 3 months agoCommitted to address real-world challenges in vaccinology
AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is building a first in class Plug & Play vaccine platform with a patented DNA based technology that launches self-amplifying live attenuated viruses. The versatile technology of AstriVax can be used to develop a wide range of vaccines to prevent and treat infectious diseases. AstriVax aims to address major challenges in vaccinology by developing novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens.
Our AstriVax team is developing a vaccine technology platform and bringing the first vaccines into clinical development.